KNOLL MEDICAL PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: G84032 | ORPINGTON, BR6 0FE
Showing results 401-450 of 638
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 30 | 434 | £382 | +48.4% ▲ | |
| 30 | 2,150 | £107 | -44.7% ▼ | |
| 30 | 2,190 | £6.9K | +154.8% ▲ | |
| 30 | 1,420 | £459 | -62.7% ▼ | |
| Ursodeoxycholic acid | 29 | 4,452 | £712 | -56.2% ▼ |
| Tapentadol | 29 | 4,312 | £2.0K | -29.6% ▼ |
| Primidone | 29 | 5,744 | £7.9K | -18.5% ▼ |
| Fosfomycin trometamol | 29 | 37 | £171 | +1.9% vs avg |
| Glimepiride | 29 | 1,112 | £31 | -68.6% ▼ |
| Betamethasone sodium phosphate | 29 | 1,622 | £212 | +135.9% ▲ |
| Water for injection | 29 | 340 | £112 | -14.3% ▼ |
| Pyridoxine hydrochloride | 29 | 1,792 | £927 | +34.9% ▲ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 29 | 1,148 | £610 | +12.9% ▲ |
| Ivermectin | 29 | 1,410 | £818 | +36.4% ▲ |
| 29 | 501 | £3.0K | +170.4% ▲ | |
| 29 | 1,888 | £4.1K | -14.1% ▼ | |
| 29 | 650 | £306 | -62.5% ▼ | |
| Indacaterol/glycopyrronium | 28 | 1,260 | £1.3K | -38.0% ▼ |
| Urine testing reagents | 28 | 1,700 | £96 | +150.4% ▲ |
| Oestrogens conjugated | 28 | 2,492 | £1.1K | +37.2% ▲ |
| Piroxicam | 28 | 2,304 | £60 | -51.3% ▼ |
| Menthol | 28 | 10.1K | £368 | -0.6% vs avg |
| 28 | 973 | £4.2K | +82.7% ▲ | |
| Naftidrofuryl oxalate | 27 | 4,200 | £499 | -17.1% ▼ |
| Celecoxib | 27 | 1,260 | £92 | -59.1% ▼ |
| Tizanidine hydrochloride | 27 | 6,064 | £512 | +1.9% vs avg |
| Ethosuximide | 26 | 2,492 | £5.2K | +76.3% ▲ |
| Mycophenolate mofetil | 26 | 4,792 | £702 | -35.8% ▼ |
| Ketorolac trometamol | 26 | 170 | £105 | +180.2% ▲ |
| Azelaic acid | 26 | 780 | £128 | +8.8% ▲ |
| 26 | 302 | £113 | -30.9% ▼ | |
| 26 | 820 | £5.0K | +125.9% ▲ | |
| Domperidone | 25 | 1,018 | £22 | -29.9% ▼ |
| Hyoscine hydrobromide | 25 | 1,740 | £276 | -26.8% ▼ |
| RtS 3.3 kcal/ml energy and higher protein liquid (0913141) | 25 | 672 | £1.3K | +260.1% ▲ |
| Metronidazole | 25 | 1,055 | £416 | -33.5% ▼ |
| 25 | 297 | £646 | +59.3% ▲ | |
| 25 | 7,500 | £84 | -0.6% vs avg | |
| 25 | 7,090 | £872 | -8.4% ▼ | |
| 25 | 660 | £3.2K | +111.1% ▲ | |
| Prasugrel | 24 | 1,344 | £271 | -23.6% ▼ |
| Zonisamide | 24 | 2,876 | £1.2K | -45.0% ▼ |
| Oxcarbazepine | 24 | 3,100 | £629 | -14.2% ▼ |
| Insulin degludec | 24 | 120 | £1.1K | -78.2% ▼ |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 24 | 454.0K | £11.6K | +125.5% ▲ |
| Azelastine hydrochloride | 24 | 208 | £158 | +101.9% ▲ |
| Zinc oxide | 24 | 7,110 | £198 | +19.3% ▲ |
| 24 | 269 | £366 | -25.8% ▼ | |
| 24 | 607 | £220 | -51.4% ▼ | |
| Telmisartan with diuretic | 23 | 1,344 | £468 | +103.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.